Search research articles
Contact Us
Filters
Showing results (151-160 of 159) with videos related to
Page
of 16
Sort By:
You have reached the last page of results.
This site can display upto 159 results.
Proceedings of the National Academy of Sciences of the United States of America
|
March 23, 2021
A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer
Lingfan Xu, Yu Yin, Yanjing Li, et al.
Urologic Oncology
|
February 21, 2013
The effect of gender and age on kidney cancer survival: younger age is an independent prognostic factor in women with renal cell carcinoma
Edward N Rampersaud, Tobias Klatte, Geoffrey Bass, et al.
European Urology
|
October 29, 2024
What's in a Name? Why Words Matter in Advanced Prostate Cancer
William K Oh, Neeraj Agarwal, Alan Bryce, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2021
Phase II Study of Gemcitabine and Split-Dose Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer
Tracy L Rose, Michael R Harrison, Allison M Deal, et al.
The Oncologist
|
June 27, 2023
Pathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following Immunotherapy
Justine Panian, Ava Saidian, Kevin Hakimi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 10, 2010
NCCN clinical practice guidelines in oncology: prostate cancer
James Mohler, Robert R Bahnson, Barry Boston, et al.
JCO Oncology Practice
|
September 28, 2020
Practical Considerations and Challenges for Germline Genetic Testing in Patients With Prostate Cancer: Recommendations From the Germline Genetics Working Group of the PCCTC
Brittany M Szymaniak, Lauren A Facchini, Veda N Giri, et al.
European Urology
|
January 24, 2025
A Call for a Neoadjuvant Kidney Cancer Consortium: Lessons Learned from Other Cancer Types
Axel Bex, Michael Jewett, Bryan Lewis, et al.
European Urology
|
December 9, 2022
Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022
Silke Gillessen, Alberto Bossi, Ian D Davis, et al.
Page
of 16
Search research articles
Search
Showing results (151-160 of 159) with videos related to
Sort By:
Page
of 16
You have reached the last page of results.
This site can display upto 159 results.
Proceedings of the National Academy of Sciences of the United States of America
|
March 23, 2021
A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer
Lingfan Xu, Yu Yin, Yanjing Li, et al.
Urologic Oncology
|
February 21, 2013
The effect of gender and age on kidney cancer survival: younger age is an independent prognostic factor in women with renal cell carcinoma
Edward N Rampersaud, Tobias Klatte, Geoffrey Bass, et al.
European Urology
|
October 29, 2024
What's in a Name? Why Words Matter in Advanced Prostate Cancer
William K Oh, Neeraj Agarwal, Alan Bryce, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2021
Phase II Study of Gemcitabine and Split-Dose Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer
Tracy L Rose, Michael R Harrison, Allison M Deal, et al.
The Oncologist
|
June 27, 2023
Pathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following Immunotherapy
Justine Panian, Ava Saidian, Kevin Hakimi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 10, 2010
NCCN clinical practice guidelines in oncology: prostate cancer
James Mohler, Robert R Bahnson, Barry Boston, et al.
JCO Oncology Practice
|
September 28, 2020
Practical Considerations and Challenges for Germline Genetic Testing in Patients With Prostate Cancer: Recommendations From the Germline Genetics Working Group of the PCCTC
Brittany M Szymaniak, Lauren A Facchini, Veda N Giri, et al.
European Urology
|
January 24, 2025
A Call for a Neoadjuvant Kidney Cancer Consortium: Lessons Learned from Other Cancer Types
Axel Bex, Michael Jewett, Bryan Lewis, et al.
European Urology
|
December 9, 2022
Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022
Silke Gillessen, Alberto Bossi, Ian D Davis, et al.
Page
of 16